Identification | Back Directory | [Name]
(S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid | [CAS]
1695562-36-7 | [Synonyms]
L-Cysteine, N-acetyl-S-(4-methylbenzoyl)- (S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid (R)-2-Acetamido-3-((4-methylbenzoyl)thio)propanoic acid | [Molecular Formula]
C13H15NO4S | [MOL File]
1695562-36-7.mol | [Molecular Weight]
281.33 |
Chemical Properties | Back Directory | [Boiling point ]
532.1±50.0 °C(Predicted) | [density ]
1.289±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
3.11±0.10(Predicted) | [color ]
White to off-white |
Hazard Information | Back Directory | [Uses]
SXC2023 is an inhibitor for solute carrier family 7 member 11 (SLC7A11). SXC2023 exhibits antitumor efficacy, and ameliorates central nervous system disorder through downregulation of glutamate export[1]. | [References]
[1] PENDERGAST AM, et al., Compositions and methods for the treatment cancer and cns disorders. WO2021030783 A1. |
|
|